VANCOUVER, British Columbia and BOSTON, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased...
VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc...
CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations...
Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations Inc. (TSX: IMI; Amex: IME...
- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market - Expanded scientific validation for PREVU(x...
Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments TORONTO, Aug. 2 /PRNewswire-FirstCall/ -- Blood tests today, skin tests tomorrow. Allstate Life...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
4 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
12 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
26 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
52 | -0.035 | -70 | 0.05 | 0.07 | 0.01 | 2290 | 0.03016549 | CS |
156 | -0.41 | -96.4705882353 | 0.425 | 0.56 | 0.01 | 3669 | 0.21797442 | CS |
260 | -0.035 | -70 | 0.05 | 1.44 | 0.01 | 92666 | 0.08246604 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales